SHARE-BASED COMPENSATION (Tables)

12 Months Ended

Oct. 31, 2025

Share-Based Payment Arrangement, Noncash Expense [Abstract]

Allocated Share-based compensation expense disclosure

The impact on our results for share-based compensation was as follows:

	Years Ended October 31,
	2025		2024		2023
	(in millions)
Cost of products and services	$	44	$	41	$	34
Research and development	15		16		13
Selling, general and administrative	70		73		65
Total share-based compensation expense	$	129	$	130	$	112

Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions

The following assumptions were used to estimate the fair value of awards granted.

	Years Ended October 31,
	2025	2024	2023
Stock Option Plan:
Weighted average risk-free interest rate	4.1%	4.4%	3.9%
Dividend yield	0.7%	0.8%	0.6%
Weighted average volatility	29%	29%	28%
Expected life	5.5 years	5.5 years	5.5 years
LTPP:
Volatility of Agilent shares	30%	28%	31%
Volatility of selected peer-company shares	16%-62%	16%-70%	22%-84%
Pair-wise correlation with selected peers	29%	30%	42%
Post-vest restriction discount for all executive awards	6.7%	6.4%	7.1%

Summary of stock option award activity

The following table summarizes employee stock option award activity of our employees and directors for 2025.

	Options Outstanding	Weighted Average Exercise Price
	(in thousands)
Outstanding at October 31, 2024	1,005	$	134
Granted	240	$	137
Exercised	(129)	$	119
Cancelled	(202)	$	144
Outstanding at October 31, 2025	914	$	134

Schedule of share-based compensation, shares authorized under stock option plans, by exercise price range

The options outstanding and exercisable for equity share-based payment awards at October 31, 2025 were as follow:

	Options Outstanding						Options Exercisable
Range of Exercise Prices	Number Outstanding	Weighted Average Remaining Contractual Life	Weighted Average Exercise Price		Aggregate Intrinsic Value		Number Exercisable	Weighted Average Remaining Contractual Life	Weighted Average Exercise Price		Aggregate Intrinsic Value
	(in thousands)	(in years)			(in thousands)		(in thousands)	(in years)			(in thousands)
$109.00 - $120.00	204	5.3	$	110	$	7,347	191	5.1	$	110	$	6,945
$120.01- $130.00	183	8.1	$	124	4,088		112	8.0	$	124	2,489
$130.01 - $140.00	211	8.8	$	138	1,857		20	7.6	$	136	216
$140.01 & Over	316	6.6	$	154	57		263	6.5	$	155	21
	914	7.1	$	134	$	13,349	586	6.4	$	134	$	9,671

Schedule of Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value

The following table summarizes the aggregate intrinsic value of options exercised and the fair value of options granted in 2025, 2024 and 2023:

	Aggregate Intrinsic Value		Weighted Average Exercise Price		Per Share Value Using Black-Scholes Model
	(in thousands)
Options exercised in fiscal 2023	$	25,303	$	41
Black Scholes per share value of options granted during fiscal 2023					$	47
Options exercised in fiscal 2024	$	22,762	$	64
Black Scholes per share value of options granted during fiscal 2024					$	41
Options exercised in fiscal 2025	$	1,384	$	119
Black Scholes per share value of options granted during fiscal 2025					$	44

Share-Based Payment Arrangement, Activity

The following table summarizes non-vested award activity in 2025 primarily for our LTPP and restricted stock unit awards.

	Shares	Weighted Average Grant Price
	(in thousands)
Non-vested at October 31, 2024	2,136	$	136
Granted	927	$	133
Vested	(815)	$	137
Forfeited	(168)	$	134
Change in LTPP shares in the year due to not meeting performance targets	(40)	$	158
Non-vested at October 31, 2025	2,040	$	134